HEALTHADD
DSPAMC - HEALTHADD
Each stock's 10,000-path forecast, rendered as light.
DSPAMC - HEALTHADD (HEALTHADD) Stock Analysis & Case Study
Is HEALTHADD a good buy? The data-driven verdict.
on the numbers it worth a closer look, a Downstox Snapshot Score of 61/100.
On the numbers, DSPAMC - HEALTHADD (HEALTHADD) worth a closer look, a Downstox Snapshot Score of 61/100, weighing a 84% model probability of trading higher in a year. Below: the full bull case, bear case, sector-relative valuation, and a probability-weighted price target for 2027–2031.
Last updated . Data snapshot for research, not investment advice.
HEALTHADD share price target 2027, 2028, 2029, 2030, 2031, a probability view
Unlike a single guessed number, this is a probability-weighted range from a 10,000-path Monte-Carlo simulation on 1.3y of HEALTHADD history (17%/yr drift, 15%/yr volatility).
| Year | Low (P10) | Median target (P50) | High (P90) | Upside vs today |
|---|---|---|---|---|
| HEALTHADD 2027 | ₹153 | ₹185 | ₹225 | +17% |
| HEALTHADD 2028 | ₹164 | ₹216 | ₹285 | +36% |
| HEALTHADD 2029 | ₹180 | ₹252 | ₹354 | +59% |
| HEALTHADD 2030 | ₹200 | ₹294 | ₹434 | +86% |
| HEALTHADD 2031 | ₹224 | ₹342 | ₹526 | +116% |
Median (P50) is the central estimate; the P10–P90 band is the 80% confidence range. Probabilities, not promises.
What is the probability HEALTHADD goes up, or doubles?
The bull case for HEALTHADD
- A 10,000-path probability model puts a 84% chance the price is higher in a year, with a median target of ₹185 (+17%).
- Relatively low volatility (15%/yr), a steadier ride than the typical mid/small-cap.
- Upside scenario: the model's optimistic (P90) 3-year path reaches ₹354.
The bear case & risks
- No model or past record guarantees future returns, treat this as one input, not a decision.
- Downside scenario: the model's pessimistic (P10) 3-year path falls to ₹180.
HEALTHADD volatility & expected range, how bumpy is the ride?
Over the last 1.3 years HEALTHADD compounded at 17%/year with annualized volatility of 15%. That volatility implies a 1-year 80% range of ₹153–₹225, the honest backbone behind any single price target.
HEALTHADD price forecast, the full 60-month probability fan
HEALTHADD price probability fan
Each band shows where 10,000 simulated paths land. The wider the fan, the more uncertainty.
Probability of key outcomes
What are the odds HEALTHADD hits common targets within the simulated horizon?
Full multi-horizon detail on the HEALTHADD price target & forecast page.
HEALTHADD MTF margin & leverage, Upstox, Zerodha, Groww, Dhan
Margin Trading Facility lets you buy HEALTHADD with part of the capital. Lower margin % = higher leverage. Rates compared across brokers (no competitor publishes this):
| Broker | Margin required | Approx. leverage |
|---|---|---|
| UpstoxCHEAPEST | 26.5% | 3.8× |
| Dhan | 30.0% | 3.3× |
Compare every broker on the HEALTHADD MTF page.
HEALTHADD vs peers,sector comparison
About DSPAMC - HEALTHADD: sector, index & market-cap context
DSPAMC - HEALTHADD (HEALTHADD) is an NSE-listed company.
How the HEALTHADD Snapshot Score & forecast are built
The Downstox Snapshot Score is a transparent, rules-based read of DSPAMC - HEALTHADD's public fundamentals plus a statistical forecast, not an analyst opinion. It rewards low-to-fair valuation, high ROE/ROCE, a strong Piotroski F-Score, a dividend, low volatility and a favourable probability of upside; it penalises rich valuations, weak capital efficiency, a low F-Score and high volatility. The price target is a 10,000-path Monte-Carlo simulation on real historical volatility, a distribution, not a single guess. The bull and bear cases are generated from the same data, so you always see both sides.
This is information, not investment advice. Do your own due diligence and consult a SEBI-registered adviser before investing.
HEALTHADD analysis, FAQs
Is DSPAMC - HEALTHADD (HEALTHADD) a good buy?
On the numbers, DSPAMC - HEALTHADD (HEALTHADD) worth a closer look, a Downstox Snapshot Score of 61/100, weighing a 84% model probability of trading higher in a year. This is a data snapshot for research, not investment advice.
Is HEALTHADD overvalued or undervalued?
Valuation ratios for HEALTHADD are tracked live on Downstox.
What is the HEALTHADD share price target for 2031?
HEALTHADD's probability-weighted 2031 median target is ₹342, with an 80% range of ₹224–₹526 (10,000-path Monte-Carlo).
What is the probability HEALTHADD doubles in 5 years?
The modelled probability of HEALTHADD reaching ₹317 (2×) within 5 years is 59%.
What is the bull case for HEALTHADD?
A 10,000-path probability model puts a 84% chance the price is higher in a year, with a median target of ₹185 (+17%). Relatively low volatility (15%/yr), a steadier ride than the typical mid/small-cap.
What are the risks in HEALTHADD?
No model or past record guarantees future returns, treat this as one input, not a decision.